Advanced Cardiovascular Toxicity Screening: Integrating Human iPSC-Derived Cardiomyocytes with In Silico Models
Anastasiya Sinitsyna, Andrey Berezhnoy, I. S. Semidetnov, Vadim Naumov, Tatyana Sergeeva, Sergey Bakumenko, М. М. Slotvitsky, Valeriya A. Tsvelaya, Агладзе Константин Игоревич
This study integrates hiPSC-derived cardiomyocytes with in silico models to assess drug-induced cardiac risks, demonstrating the platform's ability to predict clinical side effects.
Cardiovascular Toxicology · Mar 28, 2025Peer-reviewedPharmacology & Toxicology